通过增加SOCS1表达,EP300损害了抗瘤免疫力
Yanqiong Zeng1, Ying Zhou1,2, Jiayin Ruan1
1National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, China.
Journal for immunotherapy of cancer
|October 15, 2025
概括
组织素乙转移酶EP300 (E1A结合蛋白p300) 通过升调SOCS1来促进瘤免疫逃生,这抑制了抗原呈现. 抑制EP300可以通过增加CD8+T细胞透来增强抗瘤免疫力.
科学领域:
- 癌症免疫学 癌症免疫学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 瘤微环境是一个微环境.
背景情况:
- 瘤的生长取决于免疫系统的逃避.
- EP300 (E1A结合蛋白p300) 是一种表观遗传调节剂.
- EP300在免疫逃避中的作用尚不清楚.
研究的目的:
- 调查EP300对瘤免疫逃生的影响.
- 确定EP300作为免疫治疗点的潜力.
主要方法:
- 在肺腺癌组织中分析了EP300表达.
- 通过使用CRISPR-Cas9.9生成了Ep300淘汰的癌细胞.
- 在体内评估瘤生长和CD8+T细胞透.
- 利用RNA测序,ChIP测序,流细胞测量和西布洛特来探索机制.
主要成果:
- 在癌症组织中,EP300的升级调节.
- Ep300切除抑制了瘤的生长,并增加了CD8+ T细胞的透.
- EP300上调SOCS1,抑制STAT1酸化和抗原呈现基因.
结论:
- 通过SOCS1.1,EP300通过抑制抗原呈现来促进免疫逃避.
- EP300在免疫逃生中起着新的作用.
- EP300是增强抗瘤免疫力的潜在治疗点.
相关概念视频
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer-Critical Genes II: Tumor Suppressor Genes
9.4K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.4K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K


